[Cl:1][C:2]1[C:10]2[C:6](=[CH:7][N:8]([CH2:11][CH2:12][C:13]#[C:14][Si](C)(C)C)[N:9]=2)[CH:5]=[CH:4][CH:3]=1.ClC1C=CC=C2C=1N(CCC#C[Si](C)(C)C)N=C2>>[CH2:11]([N:8]1[CH:7]=[C:6]2[C:10]([C:2]([Cl:1])=[CH:3][CH:4]=[CH:5]2)=[N:9]1)[CH2:12][C:13]#[CH:14]The title compound was prepared in accordance with the general method of Example 108(B), from 7-chloro-2-(4-trimethylsilanyl-but-3-ynyl)-2H-indazole and 7-chloro-1-(4-trimethylsilanyl-but-3-ynyl)-1H-indazole (250 mg, 0.90 mmol). The crude residue was purified by flash chromatography (cyclohexane/AcOEt 9:1) to yield 44 mg (0.21 mmol, 23%) of 2-(but-3-ynyl)-7-chloro-2H-indazole as an orange oil.
불러오는 중…